2019-06846. Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 7, 2019.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

    In accordance with 21 CFR 1301.33(a), this is notice that on February 1, 2019, Synthcon, LLC, 770 Wooten Road, Unit 101, Colorado Springs, Colorado 80915 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

    Controlled substanceDrug codeSchedule
    Amphetamine1100II
    Methamphetamine1105II
    3-Fluoro-N-methylcathinone (3-FMC)1233I
    Cathinone1235I
    Methcathinone1237I
    4-Fluoro-N-methylcathinone (4-FMC)1238I
    Pentedrone (α-methylaminovalerophenone)1246I
    Mephedrone (4-Methyl-N-methylcathinone)1248I
    4-Methyl-N-ethylcathinone (4-MEC)1249I
    Naphyrone1258I
    N-Ethylamphetamine1475I
    N,N-Dimethylamphetamine1480I
    Aminorex1585I
    4-Methylaminorex (cis isomer)1590I
    Gamma Hydroxybutyric Acid2010I
    Methaqualone2565I
    Mecloqualone2572I
    JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole)6250I
    ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7035I
    JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)7118I
    JWH-073 (1-Butyl-3-(1-naphthoyl)indole)7173I
    Start Printed Page 13963
    JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)7200I
    JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole)7203I
    Alpha-ethyltryptamine7249I
    Ibogaine7260I
    CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)7297I
    CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol)7298I
    Lysergic acid diethylamide7315I
    2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7)7348I
    Tetrahydrocannabinols7370I
    Mescaline7381I
    2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 )7385I
    3,4,5-Trimethoxyamphetamine7390I
    4-Bromo-2,5-dimethoxyamphetamine7391I
    4-Bromo-2,5-dimethoxyphenethylamine7392I
    4-Methyl-2,5-dimethoxyamphetamine7395I
    2,5-Dimethoxyamphetamine7396I
    JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole)7398I
    2,5-Dimethoxy-4-ethylamphetamine7399I
    3,4-Methylenedioxyamphetamine7400I
    5-Methoxy-3,4-methylenedioxyamphetamine7401I
    N-Hydroxy-3,4-methylenedioxyamphetamine7402I
    3,4-Methylenedioxy-N-ethylamphetamine7404I
    3,4-Methylenedioxymethamphetamine7405I
    4-Methoxyamphetamine7411I
    5-Methoxy-N-N-dimethyltryptamine7431I
    Alpha-methyltryptamine7432I
    Bufotenine7433I
    Diethyltryptamine7434I
    Dimethyltryptamine7435I
    Psilocybin7437I
    Psilocyn7438I
    5-Methoxy-N,N-diisopropyltryptamine7439I
    N-Ethyl-1-phenylcyclohexylamine7455I
    1-(1-Phenylcyclohexyl)pyrrolidine7458I
    1-Phenylcyclohexylamine7460II
    1-[1-(2-Thienyl)cyclohexyl]piperidine7470I
    Phencyclidine7471II
    1-[1-(2-Thienyl)cyclohexyl]pyrrolidine7473I
    N-Ethyl-3-piperidyl benzilate7482I
    N-Methyl-3-piperidyl benzilate7484I
    N-Benzylpiperazine7493I
    4-Methyl-alphapyrrolidinopropiophenone (4-MePPP)7498I
    2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)7508I
    2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E )7509I
    2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)7517I
    2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)7518I
    2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)7519I
    2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)7521I
    2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)7524I
    2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 )7532I
    MDPV (3,4-Methylenedioxypyrovalerone)7535I
    2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe)7536I
    2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe)7537I
    2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe)7538I
    Methylone (3,4-Methylenedioxy-N-methylcathinone)7540I
    Butylone7541I
    Pentylone7542I
    alpha-pyrrolidinopentiophenone (α-PVP)7545I
    alpha-pyrrolidinobutiophenone (α-PBP)7546I
    AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)7694I
    4-Anilino-N-phenethyl-4-piperidine (ANPP)8333II
    Phenylacetone8501II
    1-Piperidinocyclohexanecarbonitrile8603II
    Alphaprodine9010II
    Anileridine9020II
    Cocaine9041II
    Etorphine (except HCl)9056I
    Diphenoxylate9170II
    Ecgonine9180II
    Heroin9200I
    Levorphanol9220II
    Meperidine9230II
    Meperidine intermediate-A9232II
    Meperidine intermediate-B9233II
    Start Printed Page 13964
    Meperidine intermediate-C9234II
    Dextropropoxyphene, bulk (non-dosage forms)9273II
    Morphine9300II
    Normorphine9313I
    Acetorphine9319I
    U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)9547I
    AH-7921 (3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide))9551I
    Acetylmethadol9601I
    Allylprodine9602I
    Alphacetylmethadol except levo-alphacetylmethadol9603I
    Alphameprodine9604I
    Alphamethadol9605I
    Benzethidine9606I
    Betacetylmethadol9607I
    Clonitazene9612I
    Diampromide9615I
    Diethylthiambutene9616I
    Dimethylthiambutene9619I
    Ketobemidone9628I
    Levo-alphacetylmethadol9648II
    1-Methyl-4-phenyl-4-propionoxypiperidine9661I
    1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine9663I
    Alfentanil9737II
    Remifentanil9739II
    Sufentanil9740II
    Carfentanil9743II
    Tilidine9750I
    Tapentadol9780II
    Fentanyl9801II
    Para-Fluorofentanyl9812I
    3-Methylfentanyl9813I
    Alpha-methylfentanyl9814I
    Acetyl-alpha-methylfentanyl9815I
    Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)9821I
    Beta-hydroxyfentanyl9830I
    Beta-hydroxy-3-methylfentanyl9831I
    Alpha-methylthiofentanyl9832I
    3-Methylthiofentanyl9833I
    Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)9834I
    Thiofentanyl9835I
    N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide9843I
    Cyclopropyl Fentanyl9845I
    Fentanyl related-compounds as defined in 21 CFR 1308.11&h)9850I

    The company plans to manufacture the above-listed controlled substances as analytical reference standards for distribution to its customers. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Dated: March 21, 2019.

    John J. Martin,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2019-06846 Filed 4-5-19; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
04/08/2019
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2019-06846
Dates:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 7, 2019.
Pages:
13962-13964 (3 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2019-06846.pdf